2024-03 |
A population pharmacokinetic model of methotrexate in Korean patients with haematologic malignancy |
British Journal of Clinical Pharmacology
|
2023-10 |
Model-informed precision dosing in vancomycin treatment |
Frontiers in Pharmacology
|
2023-05 |
Development of a population pharmacokinetic model and optimal dosing regimen of leflunomide in Korean population |
European Journal of Pharmaceutical Sciences
|
2022-12 |
Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers |
DRUG DESIGN DEVELOPMENT AND THERAPY
|
2022-05 |
A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer |
Pharmaceutics
|
2022-04 |
The Asian Pharmacometrics Network: The historical background, establishment, objectives and roles, and recent activities |
CPT: Pharmacometrics and Systems Pharmacology
|
2021-09 |
Effects of SLCO1B1 and SLCO1B3 Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers |
Journal of personalized medicine
|
2021-05 |
Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real-world Unified Parkinson's Disease Rating Scale |
CPT: Pharmacometrics and Systems Pharmacology
|
2021-05 |
Population pharmacokinetics of primaquine in the Korean population |
Pharmaceutics
|
2021-04 |
Development of a risk scoring system for predicting acute kidney injury after minimally invasive partial and radical nephrectomy: a retrospective study |
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
|
2020-07 |
Chemical Controllable Gene Drive in Drosophila |
ACS SYNTHETIC BIOLOGY
|
2020-05 |
Effects of cytochrome P450 oxidoreductase genotypes on the pharmacokinetics of amlodipine in healthy Korean subjects |
Molecular Genetics & Genomic Medicine
|
2020-02 |
Dynamic predictive model for postoperative nausea and vomiting for intravenous fentanyl patient-controlled analgesia |
ANAESTHESIA
|
2019-08 |
Predicting Disease Progression in Patients with Bicuspid Aortic Stenosis Using Mathematical Modeling |
Journal of Clinical Medicine
|
2019-08 |
Optimal Dosing Regimen of Phenytoin for Korean Epilepsy Patients: From Premature Babies to the Elderly |
JOURNAL OF PHARMACEUTICAL SCIENCES
|
2018-12 |
Population PK-PD Model of Pegylated Interferon Alfa-2a in Healthy Korean Men |
JOURNAL OF PHARMACEUTICAL SCIENCES
|
2018-11 |
Model-based assessment of the benefits and risks of recombinant tissue plasminogen activator treatment in acute ischaemic stroke |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
|
2018-10 |
An item response theory based integrated model of headache, nausea, photophobia, and phonophobia in migraine patients |
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
|
2018-05 |
Population pharmacokinetic model of levetiracetam in Korean neonates with seizures |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
|
2018-05 |
A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy |
AAPS JOURNAL
|
2018-01 |
Mechanistic Model for Blood Pressure and Heart Rate Changes Produced by Telmisartan in Human Beings |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
|
2017-03 |
Quantitative assessment of food effect on the pharmacokinetics of nano-crystallized megestrol acetate |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
|
2017-02 |
Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures |
Korean Journal of Pediatrics
|
2017-01 |
A Review of Modeling Approaches to Predict Drug Response in Clinical Oncology |
YONSEI MEDICAL JOURNAL
|
2016-12 |
Quantitative Model for the Blood Pressure Lowering Interaction of Valsartan and Amlodipine |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
|
2016-09 |
Pharmacokinetics of a nanocrystal-containing megestrol acetate formulation: A Single-Dose, Randomized, Open-Label, 2-Part, 2-Period Crossover Study in Healthy Korean Subjects |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
|
2016-07 |
Modelling of the Effect of End-Tidal Carbon Dioxide on Cerebral Oxygen Saturation in Beach Chair Position under General Anaesthesia |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
|
2016-06 |
Pore dilatation increases the bicarbonate permeability of CFTR, ANO1 and glycine receptor anion channels |
JOURNAL OF PHYSIOLOGY-LONDON
|
2015-10 |
Pharmacokinetics of a telmisartan/rosuvastatin fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
|
2014-12 |
Population pharmacokinetic analysis of diurnal and seasonal variations of plasma concentrations of cilostazol in healthy volunteers |
THERAPEUTIC DRUG MONITORING
|
2014-08 |
Pharmacokinetic Interaction between Rosuvastatin and Metformin in Healthy Korean Male Volunteers: A Randomized, Open-label, 3-period, Crossover, Multiple-dose Study |
CLINICAL THERAPEUTICS
|
2014-08 |
Pharmacokinetic Interaction between Rosuvastatin and Olmesartan: A Randomized, Open-label, 3-period, Multiple-dose Crossover Study in Healthy Korean Male Subjects |
CLINICAL THERAPEUTICS
|
2014-08 |
Pharmacokinetic Interaction between Rosuvastatin and Telmisartan in Healthy Korean Male Volunteers: A Randomized, Open-label, Two-period, Crossover, Multiple-dose Study |
CLINICAL THERAPEUTICS
|
2014-04 |
Development of a Pharmacokinetic Interaction Model for Co-administration of Simvastatin and Amlodipine |
DRUG METABOLISM AND PHARMACOKINETICS
|
2013-07 |
Pharmacokinetic Comparison of 2 Fixed-Dose Combination Tablets of Amlodipine and Valsartan in Healthy Male Korean Volunteers: A Randomized, Open-Label, 2-Period, Single-Dose, Crossover Study |
CLINICAL THERAPEUTICS
|
2013-07 |
Pharmacokinetics of Rosuvastatin/Olmesartan Fixed-Dose Combination: A Single-Dose, Randomized, Open-Label, 2-Period Crossover Study in Healthy Korean Subjects |
CLINICAL THERAPEUTICS
|
2013-03 |
Pharmacokinetic Comparison of an Orally Disintegrating Film Formulation With a Film-Coated Tablet Formulation of Sildenafil in Healthy Korean Subjects: A Randomized, Open-Label, Single-Dose, 2-Period Crossover Study |
CLINICAL THERAPEUTICS
|
2012-09 |
Modeling of the LDL cholesterol-lowering effect of atorvastatin in Korean dyslipidemic patients and non-patient volunteers. |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
|
2012-08 |
The UGT1A3*2 polymorphism affects atorvastatin lactonization and lipid-lowering effect in healthy volunteers |
PHARMACOGENETICS AND GENOMICS
|
2012-07 |
The views of patients and healthy volunteers on participation in clinical trials: An exploratory survey study |
CONTEMPORARY CLINICAL TRIALS
|
2012-04 |
A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy |
INVESTIGATIONAL NEW DRUGS
|
2011-12 |
Pharmacokinetic Comparison of Sustained- and Immediate-Release Oral Formulations of Cilostazol in Healthy Korean Subjects: A Randomized, Open-Label, 3-Part, Sequential, 2-Period, Crossover, Single-Dose, Food-Effect, and Multiple-Dose Study |
CLINICAL THERAPEUTICS
|
2011-08 |
The effect of beta1-adrenergic receptor gene polymorphism on prolongation of corrected QT interval during endotracheal intubation under sevoflurane anesthesia |
Korean Journal of Anesthesiology
|
2011-06 |
Population pharmacokinetics of amikacin in a Korean clinical population |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
|
2011-05 |
The T2-Shortening Effect of Gadolinium and the Optimal Conditions for Maximizing the CNR for Evaluating the Biliary System: a Phantom Study |
KOREAN JOURNAL OF RADIOLOGY
|
2011-03 |
Rifampin Enhances the Glucose-Lowering Effect of Metformin and Increases OCT1 mRNA Levels in Healthy Participants |
CLINICAL PHARMACOLOGY & THERAPEUTICS
|
2011-01 |
Effect of CYP2B6 Genotype on the Pharmacokinetics of Sibutramine and Active Metabolites in Healthy Subjects |
JOURNAL OF CLINICAL PHARMACOLOGY
|
2010-12 |
PEG-인터페론 알파-2a 제제 DA-3021의 안전성 및 약동력학적 특성 연구 |
Journal Of Korean Society For Clinical Pharmacology And Therapeutics
|
2010-10 |
Modeling the Effect of Sevoflurane on Corrected QT Prolongation A Pharmacodynamic Analysis |
Anesthesiology
|
2010-07 |
A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer |
Investigational New Drugs
|
2010-01 |
Prognostic Factors in Small Cell Lung Cancer: A New Prognostic Index in Korean Patients |
Oncology
|
2010-01 |
Pharmacokinetic Comparison of Controlled-Release and Immediate-Release Oral Formulations of Simvastatin in Healthy Korean Subjects: A Randomized, Open-Label, Parallel-Group, Single- and Multiple-Dose Study |
Clinical Therapeutics
|
2009-12 |
Nerve growth factor and expression of its receptors in patients with diabetic neuropathy |
Diabetic Medicine
|
2009-06 |
Pharmacokinetic properties and tissue storage of FITC conjugated SA-MnMEIO nanoparticles in mice |
Current Applied Physics
|
2009-01 |
Phase II Study of Transarterial Holmium-166-Chitosan Complex Treatment in Patients with a Single, Large Hepatocellular Carcinoma |
Oncology
|
2008-02 |
Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans |
Clinical Pharmacology & Therapeutics
|
2007-08 |
Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
|
2007-01 |
A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults |
CLINICAL THERAPEUTICS
|
2006-08 |
Bispectral index does not correlate with observer assessment of alertness and sedation scores during 0.5% bupivacaine epidural anesthesia with nitrous oxide sedation |
ANESTHESIA AND ANALGESIA
|
2005-01 |
국내인에서의 항생제 약동학 모델링 : 아미카신의 적용예 |
감염과화학요법
|
2000-08 |
Race and sex influence clearance of nifedipine: Results of a population study |
CLINICAL PHARMACOLOGY & THERAPEUTICS
|
1998-03 |
Passive versus electrotransport-facilitated transdermal absorption of ketorolac |
CLINICAL PHARMACOLOGY & THERAPEUTICS
|
1998-01 |
Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input profile |
Journal of Pharmacokinetics and Biopharmaceutics
|
1997-11 |
Pharmacokinetics of saquinavir zidovudine and zalcitabine in combination therapy |
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
|
1997-10 |
A semiparametric method for describing noisy population pharmacokinetic data |
Journal of pharmacokinetics and biopharmaceutics
|
1997-10 |
Uncertain pharmacokinetic/pharmacodynamic systems: Design estimation and control |
Control Eng Practice
|